Drought Across the US Crushes ADM’s Margins

August 1, 2012

Drought and weak gasoline demand crushed Archer Daniels Midland’s margins in its fiscal fourth quarter. We think shares are fairly valued.

Coach’s Fourth Quarter Results Hurt by North America

July 31, 2012

Retailer Coach reported results that were in-line with expectations. However, the road ahead looks choppy.

Pfizer Reports Decent Second Quarter Results; Plans to Spin Off Animal Health Business

July 31, 2012

Pfizer posted decent second-quarter results that showed strong cost containment in the face of declining sales of its blockbuster drug Lipitor. The company also announced plans to spin off its animal health business to focus on its core pharma business. We maintain our view that Pfizer is significantly underpriced.

The US Housing Market Is Back

July 30, 2012

The housing market in the United States has regained its footing and looks poised to rebound even further. First, on Thursday, PulteGroup (click ticker for report: PHM) reported better-than-expected second-quarter earnings, generated 15% revenue growth, and showed that its backlog grew 31% year-over-year on a unit basis. Then, on Friday, D.R. Horton’s (click ticker for report: DHI) fiscal third-quarter results revealed its backlog advanced 25% year-over-year. Plus, the firm reversed a tax-asset write-down, indicating the company expects increased profitability down the road. The strong performance from these two builders was preceded by solid results from other builders including KB Home (click ticker for report: KBH) and Lennar (click ticker for report: LEN). Though conventional wisdom may suggest a weak economic

Strong Growth Continues at Whole Foods Market

July 30, 2012

Whole Foods Market (click ticker for report: WFM) continues to stand out among grocers, reporting yet another stellar quarter. During its fiscal year 2012 third quarter, the grocery store chain, known for its healthier product offerings, saw same-store sales increase 8.2% in spite of the Easter and 4th of July shift. Total sales surged nearly 14% compared to the same period a year ago to $2.7 billion, which was in-line with expectations. Earnings per share grew 26% year-over-year to $0.63, which was slightly more than the Street expected. As a result of strong earnings growth, the firm generated $401.3 million in free cash flow during its third quarter. This is quite different from its older competitors—namely SuperValu (click ticker for

Decker’s Second Quarter Results Were Strong Despite the Headline Loss

July 30, 2012

Footwear firm Deckers reported a strong second quarter. We think shares are undervalued and that the firm’s weakness was a result of seasonal factors.

Chevron Boasts Strong Downstream Performance in Second Quarter

July 27, 2012

Though Chevron’s second-quarter net income fell, we were very pleased with performance in its downstream business. The firm remains a core holding in the portfolio of our Dividend Growth Newsletter.

Merck Reports Solid Second Quarter; Its Drug Pipeline Looks Promising

July 27, 2012

Merck reported solid second quarter results and indicated that progress in its pipeline remains strong. Though the firm will face patent expiration of its blockbuster Singulair in coming weeks, we think shares remain fairly valued.

Dividend Growth Gem Republic Services Reports Strong Second Quarter; Raises Dividend

July 27, 2012

Dividend growth gem Republic Services hiked its dividend 7% as it works to get its operations back on track. The garbage hauler’s second quarter was decent, and its debt refinancings suggest continued strong dividend growth for years to come.

Amazon’s Profits Fall Short in Its Second Quarter

July 27, 2012

Amazon reported weak second-quarter results as profits plummeted and free cash flow dropped considerably. Though we have no qualms about the online retailer’s revenue expansion, we’d like to see more robust profit-generation before considering it in our Best Ideas portfolio.

Previous Next

About Our Name

But how, you will ask, does one decide what [stocks are] "attractive"? Most analysts feel they must choose between two approaches customarily thought to be in opposition: "value" and "growth,"...We view that as fuzzy thinking...Growth is always a component of value [and] the very term "value investing" is redundant.

                         -- Warren Buffett, Berkshire Hathaway annual report, 1992

At Valuentum, we take Buffett's thoughts one step further. We think the best opportunities arise from an understanding of a variety of investing disciplines in order to identify the most attractive stocks at any given time. Valuentum therefore analyzes each stock across a wide spectrum of philosophies, from deep value through momentum investing. And a combination of the two approaches found on each side of the spectrum (value/momentum) in a name couldn't be more representative of what our analysts do here; hence, we're called Valuentum.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Valuentum Exclusive publication, ESG Newsletter, and any reports, data and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, data or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor, and does not offer brokerage or investment banking services. The sources of the data used on this website and reports are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum, its employees, and independent contractors may have long, short or derivative positions in the securities mentioned on this website. The High Yield Dividend Newsletter portfolio, ESG Newsletter portfolio, Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio are not real money portfolios. Performance, including that in the Valuentum Exclusive publication and additional options commentary feature, is hypothetical and does not represent actual trading. Actual results may differ from simulated information, results, or performance being presented. For more information about Valuentum and the products and services it offers, please contact us at info@valuentum.com.